Helix BioPharma Corp.
TSX:HBP.TOBiotechnology
-$0.07 today
- Market cap
- $65.69M
- Beta
- -0.29
- P/E (TTM)
- -32.6
- EPS (TTM)
- -$0.04
Volume 0.00M
Average 0.00M
Balance Sheet
Inspect the capital base behind the business.
Assets
$18.80M
FY 2025 · Annual
+1162.7% YoYLiabilities
$3.22M
FY 2025 · Annual
+103.7% YoYEquity
$15.59M
FY 2025 · Annual
Balance Sheet
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $2.8M |
| Receivables | $28.0K |
| Other Current | $122.0K |
| Total Current Assets | $3.0M |
| PP&E (Net) | $1.0K |
| Intangible Assets | $18.4M |
| Total Non-current Assets | $18.4M |
| Total Assets | $21.4M |
Analysis
Selected assets total $21.4M for Latest. The largest visible component is Intangible Assets at $18.4M, about 86.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
No filings found.
How much cash does HBP.TO have?
Helix BioPharma Corp. (HBP.TO) reported $65,000.00 in cash and equivalents in fiscal 2025.
How much debt does HBP.TO carry?
Helix BioPharma Corp. (HBP.TO) reported $335,000.00 of total debt, with net debt of $270,000.00.
Continue the stock analysis
Jump to another research area for this company.